Msdc 0160 Buy ✦ Tested & Updated

By modulating mitochondrial metabolism, it prevents the over-activation of mTOR , a key nutrient sensor that, when overactive, is linked to neurodegeneration and inflammation. 🧠 Therapeutic Applications

In preclinical models, MSDC-0160 protected dopaminergic neurons, improved motor function, and reduced neuroinflammation.

It helps cells maintain "trash removal" systems (autophagy), preventing the toxic buildup of proteins like -synuclein . msdc 0160 buy

MSDC-0160 is a novel, clinical-stage drug candidate originally developed for . It is the prototype of a new class of insulin sensitizers called mTOT Modulators (Mitochondrial Target of Thiazolidinediones). Unlike first-generation insulin sensitizers like pioglitazone, MSDC-0160 is PPAR

It blocks the entry of pyruvate into the mitochondria, the main gateway for carbohydrate metabolism. -sparing , meaning it avoids many common side

-sparing , meaning it avoids many common side effects like weight gain and fluid retention. Core Pharmacology and Mechanism

This forced "metabolic shift" encourages cells to use alternative fuel sources like ketones and fatty acids through -oxidation. MSDC-0160 is a novel

It may prevent or reverse dyskinesia (involuntary movements) caused by standard Parkinson's medications. 2. Alzheimer’s Disease (AD) MSDC-0160 - Metabolic Solutions Development Company